维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="DHAENE G"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures显示文摘	Dhaene K Vanacoillie G Lambert J	2000	Br J Cancer2000，82，5：	1
2	K-RAS status and efficacy in the first-line treatment ofpatients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: the CRYSTAL experience显示文摘	Van CUTSEM E LANG I DHAENS G	2008	J Clin Oncol2008，26，15：	1
3	Upper and lower bounds for sums of random variables显示文摘	Kaas R Dhaene J Marc J G	2000	Insurance Mathematics & Economics2000，，27：	1
4	Infliximab Induces Potent Anti-Inflammatory and Local Immunomodulatory Activity But no Systemic Immune Suppression in Patients with Crohn's Disease显示文摘	CORNILIC F SHCALY D DHAENS G	2001	Aliment Pharmacol Ther2001，15，4：	1
5	Development and validation of a new,simplified endoscopic activity score for Crohn(s)disease:the SES-CD显示文摘	DAPERNO M DHAENS G Van ASSCHE G	2004	Gastrointest Enclose2004，60，：	1
6	KRAS status and efficacy in the first- line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIR1 with or without cetuximab: The CRYSTAL experlence显示文摘	Van Cutsem E Lang L Dhaens G	2005	J Clin Oncol2005，，：	1
7	A rev- iew of activity indices and efficacy end points for clinical trims of medical therapy in adults with ulcerative colitis 显示文摘	DHAENS G SANDBORN W J FEAGAN B G	2007	Gastroenterology2007，132，2：	1
8	Development of the Paris definition of early Crohn' s disease for disease- modification trims: results of an international expert opinion process 显示文摘	Peyrin-Biroulet L Billioud V DHaens G	2012	Am J Gastroenterol2012，107，12：	1
9	K-RAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIR1 with or without cetuximab : the CRYTAL experience 显示文摘	VAN CUTSEM E LANG I DHAENS G	2008	J Clin Oncol2008，26，：	1
10	K-RAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: the CRYTAL experience 显示文摘	Van Cutseme Lang I Dhaens G	2008	J Clin Oncol2008，26，：	1
11	K-RAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetux-imab:the CRYTAL experience显示文摘	Van Cutseme Lang I Dhaens G		0，，1：	1
12	A review of activity indi- ces and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis 显示文摘	DHaens G Sandborn WJ Feagan BG	2007	Gastroenterology2007，132，2：	1
13	Sequential reciprocity in two-player, two-stage games: An experimental analysis显示文摘	Dhaene G Bouckaert J	2010	Games and Economic Behavior2010，，70：	1
14	Cediranib with mFOL- FOX6 vs bevacizumab with mFOLFOX6 in previously treated meta- static coloreetal cancer显示文摘	Cunningham D Wong RP DHaens G	2013	Br J Cancer2013，108，3：	1
15	Testing the martingale hypothesis for futures prices: Implications for hedgers 显示文摘	De Ville de Goyet C Dhaene G Sercu P	2008	Journal of Futures Markets2008，28，11：	1
16	Absence of telomerase activity and telemorase catalytic subunit mRNA inmelanocyte cultures显示文摘	Vancoillie G Lambert J	2000	Br J Cancer2000，82，：	1
17	Physics-based passivity-preserving parameterized model order reduction for PEEC circuit analysis显示文摘	FERRANTI F ANTONINI G DHAENE T	2011	IEEE Trans on Copmponents Packaging and Manu- facturing Technology2011，1，3：	1
18	Sequential reciprocity in two-player, two-stage games :an experimental analysis 显示文摘	DHAENE G BOUCKAERT J	2010	Gamesand Economic Behavior2010，70，2：	1
19	Absence of telomerase activity and telemorase catalytic subunit mRNA in melanocyte cultures显示文摘	Dhaene K Vancoillie G Lambert J	2000	Br J Cancer2000，82，5：	1
20	KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer(mCRC ) treated with FOLFIRI with or without cetux-imab:the CRYSTAL experience显示文摘	Van Cutsem E Lang I Dhaens G	2008	J Clin Oncol2008，26，20：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示